NanoSight supplies instrumentation for the visualisation of nanoparticles in real time.
NanoSight’s “Nanoparticle Tracking Analysis” detects and visualises nanoparticles in liquids down to 10 nanometres. The technology is based on the measurement of the scattering of laser light. The NanoSight instruments measure size, size distribution, concentration, charge and fluorescence on a particle by particle basis. The technology has found application in a wide range of research and commercial applications. The NanoSight instruments are also increasingly being used for the development of drug discovery systems, viral vaccines and in nanotoxicology.
TVP invested in NanoSight at an early stage of its development. NanoSight was acquired by Spectris plc in September 2013 for £15m.